| PYFLAZ IDORSIA PHARMACEUTICALS LTD.
1837196 11 May 2017 | on 08 Apr 2021 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for cardiovascular indications, for the treatment of inflammatory connective tissue diseases and injuries, for the treatment of cancer, the treatment of the central nervous system, namely, central nervous system infections, brain diseases and central nervous system movement disorders, and for the treatment of vasospasms associated with aneurysmal subarachnoid hemorrhage (aSAH) | | | PYVLAZ IDORSIA PHARMACEUTICALS LTD.
1837197 11 May 2017 | on 29 Dec 2020 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for cardiovascular indications for the treatment of inflammatory connective tissue diseases and injuries, for the treatment of cancer, for the treatment of the central nervous system, namely, central nervous system infections, brain diseases and central nervous system movement disorders, and for the treatment of vasospasms associated with aneurysmal subarachnoid hemorrhage (aSAH) | | 
